ArticleFrontiers in pharmacology2026

HER2-mutated lung squamous cell carcinoma responding to trastuzumab deruxtecan followed by pyrotinib: a Case Report.

Lou Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.